Multiple myeloma

You are here: 

Consolidation therapy for multiple myeloma

Consolidation therapy for multiple myeloma is given after a stem cell transplant. It’s a short course of chemotherapy that helps make the previous chemotherapy treatment and stem cell transplant work better. Consolidation therapy also helps to keep the multiple myeloma in remission for longer.

Consolidation therapy for people with multiple myeloma who have had a stem cell transplant is most often the VRD regimen. The VRD regimen uses bortezomib (Velcade), lenalidomide (Revlimid) and dexamethasone (Decadron, Dexasone).

Stories

Dr Xiaoyan Jiang Dr Xiaoyan Jiang found a way to predict how a type of leukemia will respond to treatment.

Learn more

Trusted online community of support

Illustration of computer

Cancerconnection.ca provides a trusted online community for cancer patients, their family and friends.

Learn more